Literature DB >> 8220427

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.

J P Kerckaert1, C Deweindt, H Tilly, S Quief, G Lecocq, C Bastard.   

Abstract

We have shown previously that chromosomal translocations involving chromosome 3q27 and immunoglobulin gene regions are the third most common specific translocations in non-Hodgkin's lymphoma (NHL). We now report the isolation of a gene that is disrupted in two cases by t(3;14) and t(3;4) translocations. The gene (LAZ3) encodes a 79 kDa protein containing six zinc-finger motifs and sharing amino-terminal homology with several transcription factors including the Drosophila tramtrack and Broad-complex genes, both of which are developmental transcription regulators. LAZ3 is transcribed as a 3.8 kb message predominantly in normal adult skeletal muscle and in several NHL carrying 3q27 chromosomal defects. We suggest that it may act as a transcription regulator and play an important role in lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220427     DOI: 10.1038/ng0993-66

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  84 in total

1.  A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

Authors:  T Chen; F M Boisvert; D P Bazett-Jones; S Richard
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

Review 2.  In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Authors:  J E Sale; M Bemark; G T Williams; C J Jolly; M R Ehrenstein; C Rada; C Milstein; M S Neuberger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

3.  NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat.

Authors:  S A Mackler; L Korutla; X Y Cha; M J Koebbe; K M Fournier; M S Bowers; P W Kalivas
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

5.  Prognostic value of immunohistochemical biomarkers at different cut-off values in patients with diffuse large B-cell lymphoma treated with CHOP chemotherapy.

Authors:  Sukjoong Oh; Dong Hoe Koo; Cheolwon Suh; Shin Kim; Bong Hee Park; Joon Kang; Jooryung Huh
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

Review 6.  Epigenetic therapy of lymphoma using histone deacetylase inhibitors.

Authors:  Maribel Cotto; Fernando Cabanillas; Maribel Tirado; María V García; Eileen Pacheco
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

7.  Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Authors:  Tiemo Katzenberger; German Ott; Thomas Klein; Jörg Kalla; Hans Konrad Müller-Hermelink; M Michaela Ott
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 8.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

9.  BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning.

Authors:  Daisuke Sakano; Akiko Kato; Nisarg Parikh; Kelly McKnight; Doris Terry; Branko Stefanovic; Yoichi Kato
Journal:  Dev Cell       Date:  2010-03-16       Impact factor: 12.270

10.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.